Solution Spotlight: Within3
Within3’s disease community analytics provide an understanding of influence within a disease community – not just expertise.
A next-generation mindset: Veeva Commercial Summit 2024
Imagine a time when all your teams collaborate seamlessly. That’s what this year’s Veeva Commercial Summit posited as it commenced.
Coming soon: The Life Sciences Industry Report 2025 – insigh...
Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn
Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Novartis raises mid-term sales outlook on pipeline promise
Novartis has raised its guidance for sales growth out to 2029 on the strength of its pipeline and the potential of late-stage R&D assets
Featured Content
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
9th Commercialising Continuous Processing Summit 2025
The pivotal shift in biopharma priorities is steering towards enhancing sustainability measures for drug development.
9th Liquid Biopsy for Precision Oncology Summit
9th Liquid Biopsy for Precision Oncology Summit | February 18-20, 2025 | San Diego, CA | FREE* to Attend for Biopharma
Returning... The 5th Operationalize Expanded Access Programs...
Welcome to, or welcome back to, the 5th Operationalize: Expanded Access Programs Summit 2025!
LEAP HR: Life Sciences Europe
Save the Date for LEAP HR: Life Sciences Europe! 18th-20th February, 2025, London, UK.
Patient Recruitment for Rare Disease Trials Summit
Recruiting patients for rare disease trials is akin to finding a needle in a haystack, with challenges such as geographical dispersion, low awareness, and limited eligible patient pools.